ANCHOR Registry and publications

Wide neck cohort (n = 72)

Wide proximal aortic necks experience suboptimal outcomes after standard EVAR
Wide necks  are1:
  • 6.7 times more likely to have type Ia endoleak (p = 0.001)
  • 10 times more likely to have sac expansion (p = 0.009)
  • 5.1 times more likely to rupture (p = 0.01)

(N = 6,602 f/u ranged from 2.7 years [mean] to 3.9 years)


ESAR in wide necks: reinforced seal2,3, redefined outcomes4–8
ANCHOR Registry wide neck data 

ESAR reinforces and protects the proximal seal, leading to better outcomes in wide necks. View data on wide necks from literature compared to the three-year wide neck results from the ANCHOR Registry.

ANCHOR Registry wide neck cohort three-year data (N = 72)5

(Wide necks ≥ 28 mm and ≤ 32 mm mean neck diameter 29.5 mm)

  • 98.5% three-year FF type Ia endoleak (One patient presented with a type Ia at their 30-day follow-up, self-resolved)
  • 100% three-year FF secondary procedures to treat type Ia
  • 100% three-year FF migration
  • 100% three-year FF rupture
  • 93.4% (28/30) sacs regressing/stable at three years
  • 66.7% (20/30) sac regression at three years

The relevance of ANCHOR Registry wide neck data

Hear from Professor Michel Reijnen on the importance of the ANCHOR three-year wide neck data. (03:33)


Using the ANCHOR Registry to help treat patients

Dr. William Jordan Jr. discusses the ANCHOR Registry and how it captures real-world usage and long-term outcomes of EndoAnchor™ implant fixation in EVAR. (01:10)

Primary AAA arm (n = 771)4

ANCHOR Registry real-world outcomes

Learn about the ANCHOR Registry design methods, results, and proven durability of ESAR with the Heli-FX™ EndoAnchor™ system in challenging AAA patients. (02:21)


Baseline patient characteristics
  1. Infrarenal neck diameter: 23.9 mm (mean)
  2. Infrarenal angulation: 36.6° (mean)
  3. Aneurysm diameter: 59.3 mm (mean)
  4. Neck length: 15.0 mm (median)
  5. Conical neck (> 10%/10 mm): 42.5% (276/649)
Stent graft used (N = 750)
  • Endurant™ II/IIs stent graft system: 61.5%
  • Excluder™* AAA endoprosthesis: 26%
  • Zenith™* AAA endovascular graft: 9.9%
  • Other: 2.6%

ANCHOR primary AAA arm N = 771
Female 21.3% 
Average age 73.5 years
Hostile necks 88.7% (572/645) 
ASA Class III/IV 87.8% (674/768)
Urgent or emergent 17.9% (119/664) 
Perioperative outcomes
ANCHOR primary AAA arm N = 771
Technical success9 98.8% (738/747)
Average time to place EndoAnchor™ implants 19.6 min
Average number of EndoAnchor™ implants 6.0
Average total procedural time9 143.7 min
Average total fluoro time 35.1 min
Outcomes10
ANCHOR primary AAA arm (N = 771) Year 1 Year 2 Year 3 Year 4 Year 5
Type Ia endoleak 2.5%
(14/568)
1.7%
(6/346)
2.9%
(7/238)
3.2%
(5/154)
4.8%
(4/84)
Migration 0.0% 
(0/368)
0.0% 
(0/180)
0.0% 
(0/114)
0.0%
(0/72)
0.0%
(0/37)

ESAR promotes sac regression

Strong five-year sac regression in hostile necks

  • 62.5% (50/80) sac regressing
  • 88.8% (71/80) of stable or regressing

Long-term clinical durability (N = 771)

ANCHOR five-year results demonstrate durable, reinforced proximal seal

  • >89.0% FF type Ia endoleak10
  • 96.0% FF reinterventions for type Ia
  • 97.7% FF rupture
  • 98.4% FF aneurysm-related mortality (ARM)

Revision AAA arm (n = 261)11

Baseline patient characteristics
  1. Infrarenal neck diameter: 26.3 mm (mean)
  2. Infrarenal angulation: 35.6° (mean)
  3. Aneurysm diameter: 69.9 mm (mean)
  4. Neck length: 15.0 mm (median)
  5. Conical neck (> 10%/10 mm): 42.0% (89/212)
Stent graft used (N = 260)
  • Endurant II/IIs stent graft system: 23.5%
  • Excluder AAA endoprosthesis: 19.6%
  • AneuRx™: 14.6%
  • Zenith AAA endovascular graft: 13.8%
  • Talent™*: 11.2%
  • Other: 17.4%

Reasons for EndoAnchor™ therapy
  • 53.6% type Ia endoleak
  • 18.4% migration and type Ia endoleak
  • 3.0% migration (without endoleak)
  • 7.3% neck dilatation
  • 7.7% other
ANCHOR revision AAA arm N = 261
Female 15.3%
Average age 77.8 years
Hostile necks 88.7% (188/212)
ASA Class III/IV 89.2% 
Urgent or emergent 23.8% (58/244)
Perioperative outcomes
ANCHOR revision AAA arm N = 261
Technical success 95% 
Average time to place EndoAnchor™ implants 25.2 min
Average number of EndoAnchor™ implants 7.4
Average total procedural time 145.5 min
Average total fluoro time 32.5 min

Outcomes

(For 4.6 years, see reference 12.)

ANCHOR revision AAA arm (N = 261) Year 5
Type Ia endoleak9 3.7% (1/27)
Sac regressing or stable11 65.4% (17/26)
Sac regressing11 38.5% (10/26)
Migration9 0.0% (0/16)

Durable repair in failed EVAR (N = 261)

Five-year revision results over nine years post-index EVAR
Even in failed EVARs, ESAR delivers durability

  • 91.3% five-year FF ARM
  • 91.1% five-year FF rupture
  • 81.4% five-year FF reinterventions to treat type Ia

Short neck cohort (n = 70)13

Baseline patient characteristics (core lab reported)
  1. Infrarenal diameter: 25.7 mm
  2. Infrarenal angulation: 20.6°
  3. Aneurysm diameter: 57.7 mm
  4. Core lab mean neck length: 6.9 mm
  5. Site recorded mean neck length: 12.1 mm
ANCHOR short neck cohort N = 70
Female 27%
Average age 71 years
Hostile necks 100%
ASA Class III/IV 93%
Urgent or emergent 31%

Perioperative outcomes
ANCHOR short neck cohort N = 70
Overall procedural success 97.1%
Successful and accurate deployment of EndoAnchor implants14 92.9%
Average time to place EndoAnchor implants 17.1 min
Average number of EndoAnchor implants 5.5
Average total procedural time 148 min
Average total fluoro time  35.5 min
Outcomes (site reported values)
ANCHOR short neck cohort (N = 70) Year 1 Year 2 Year 3
Type Ia endoleak 2.0%
(1/51)
2.7%
(1/37)
6.5%
(2/31)
Sac regressing or stable 100%
(53/53)
97.3%
(36/37)
93.7%
(30/32)
Sac regressing 35.8%
(19/53)
54.1%
(20/37)
46.9%
(15/32)
Migration 0 migrations
at any time point
ESAR in short necks (N = 70)

Durable results, minimal reinterventions

Short neck cohort three-year results demonstrate strong outcomes and minimal reinterventions in hostile neck patients

  • 98.5% three-year FF secondary reinterventions for type Ia15
  • 88.0% three-year FF all reinterventions
  • 98.0% three-year FF rupture15
  • 92.4% three-year FF ARM

Related links